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The pathophysiology of asthma involves an interaction between several cells, such as neutrophils, mast cells, eosinophils and 
lymphocytes, and their mediators. This interaction 
gives rise to chronic inflammation of the already 
hyper-responsive airways resulting in severe yet 
reversible airflow limitation. This is responsible for the 
coughing, wheezing, chest tightness and shortness of 
breath commonly seen in asthmatic patients.1
Despite an adequate understanding of the 
underlying mechanism of this disease and the relative 
ease and availability of treatment, asthma continues to 
be a major health concern around the world. According 
to estimates from the World Health Organization, 
about 300 million of the world’s population suffer 
from asthma.2 It is a major contributor of morbidity 
in both children and adults, and an important cause 
of mortality as well, causing an estimated 250,000 
premature deaths annually.3 It is no surprise then that 
asthma represents a significant economic burden on 
healthcare systems. A study in the USA estimated 
the annual direct medical expenditure for asthma 
treatment in 2007 to be $37.2 billion.4 
Individuals who have a poor level of control 
over their asthma may face difficulties not only 
physiologically, but also psychologically and socio-
economically. Therefore, the goal of treatment in 
these patients is to improve health status, and, in turn, 
quality of life.
Prevalence of Asthma in Oman
Although no studies have yet been conducted in Oman 
to determine the prevalence of asthma, Oman was one 
of the few Gulf Cooperative Council (GCC) countries 
to participate in the International Study of Asthma 
and Allergies in Childhood (ISAAC).5 The ISAAC 
Epidemiological Research Program was established in 
1991 due to the rise in the prevalence and severity of 
asthma and allergic disorders, which highlighted the 
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abstract: Asthma is a common lung disease worldwide, although its prevalence varies from country to country. 
Oman is ranked in the intermediate range based on results from the International Study of Asthma and Allergies 
in Childhood. A 2009 study revealed that the majority of asthmatic patients in Oman reported both daytime and 
nocturnal symptoms, while 30% of adults and 52% of children reported absences from work or school due to their 
symptoms. Despite these findings, there is little data available on the economic burden of asthma in Oman. The 
only accessible information is from a 2013 study which concluded that Oman’s highest asthma-related costs were 
attributable to inpatient (55%) and emergency room (25%) visits, while asthma medications contributed to less 
than 1% of the financial toll. These results indicate a low level of asthma control in Oman, placing a large economic 
burden on healthcare providers. Therefore, educating asthmatic patients and their families should be prioritised 
in order to improve the management and related costs of this disease within Oman.
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امللخ�ص: الربو هو مر�ض رئوي �سائع يف كل اأنحاء العامل، غري اأن معدل انت�ساره يختلف من قطر الآخر. وبح�سب نتائج درا�سة عاملية عن 
معدالت انت�سار الربو وفرط التح�س�ض )االأرجية( عند االأطفال، يعد معدل انت�سار هذه االأمرا�ض يف اأطفال عمان متو�سط امل�ستوى. واأو�سحت 
درا�سة ن�رشت يف عام 2009م اأن اأغلب مر�سي الربو يف عمان ي�سكون من اأعرا�ض هذا املر�ض يف النهار والليل معا، واأن نحو %30 من 
البالغني و%52 من االأطفال يغيبون عن العمل اأو الدرا�سة ب�سبب اأعرا�ض الربو. ورغم هذه النتائج، اإال اأنه ال تتوفر اأي معلومات عن العبء 
االقت�سادي للربو يف عمان. ولي�ض هنالك غري مرجع واحد عن هذا املو�سوع، والذي اأو�سح اأن عبء الربو يف عمان يتمثل يف ال�رشف 
على املر�سى املنومني )%55( ويف غرفة الطوارئ )%25(، وال ت�سكل اأدوية الربو �سوى اأقل من %1 من العبء املايل. وت�سري هذه الدرا�سة 
اإىل امل�ستوى املنخف�ض ملكافحة الربو يف عمان، مما ي�سع عبئا اقت�ساديا كبريا على اأكتاف مقدمي اخلدمات ال�سحية. لذا يجب اأن تكون 
عمليات تعليم واإر�ساد مر�سى الربو من االأولويات، حتى يتح�سن التدبري العالجي للمر�ض وتقل تكاليفه يف عمان.
مفتاح الكلمات: العبء االقت�سادي؛ الربو؛ اأمرا�ض الرئة؛ عبء املر�ض؛ عمان.
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year. Exercise-induced wheezing was more prevalent 
among older children (19.2% versus 6.9%; P <0.001).18
Among the Eastern Mediterranean countries 
participating in the ISAAC Program, Oman showed 
the highest prevalence of asthma in children, although 
it was in the intermediate range of the ISAAC global 
ranking. Over the three phases, Omani children were 
found to have a relatively high prevalence of severe 
asthma symptoms, including sleep disturbances and 
speech-limiting wheezing.19 Different results were 
noted in the prevalence of asthma, its diagnosis 
and symptoms (depending on the participants’ 
geographical regions in Oman). In the east, the Ash 
Sharqiyah region scored the highest prevalence of 
self-reported asthma diagnoses and the presence of all 
asthma symptoms in both age groups over the six-year 
period between the first and third ISAAC phases.20 
The participants in the younger group displayed a 
significant increase in the prevalence of wheezing (8.7–
13.8%; P = 0.002) and asthma diagnoses (13.8–17.8%; 
P = 0.046) over a period of 12 months during ISAAC 
phase three, while those in the older group showed 
an increase in nighttime coughing (21.6–27.8%; P 
= 0.039) in the same time frame. None of the other 
regions were found to have a change in prevalence 
from that indicated by the initial study in 1995, with 
some regions even showing a declining trend in a few 
self-reported asthma symptoms.21
A cause for concern is the finding in both ISAAC 
phase one and two surveys that over 60% of current 
wheezers reported severe asthma symptoms, even 
though only 60% reported an asthma diagnosis.7‒9 
This highlights the fact that asthma was not only 
underdiagnosed in the data collected, but that the 
symptoms of the condition were poorly recognised 
with no indication of improvement over time. 
Oman was not able to formally participate in the full 
ISAAC phase two protocol due to cost and logistics. 
However, a similar study using the same questionnaire 
was conducted, with the addition of a few questions 
addressing the use of Arabian incense.22 
Arabian incense, which is also called frankincense 
or aluban, is an aromatic resin obtained from trees of 
the genus Boswellia. It is burnt using wood charcoal, 
which is a common practice in Omani households. 
A study of aluban’s effect on asthma symptoms was 
conducted to investigate the potential risk factors for 
asthma and allergies in two representative regions of 
Oman.19,22 A total of 2,441 school-going 10-year-olds 
were used as the target sample, having been selected 
randomly from public schools in the Muscat (n = 
1,241) and south Ash Sharqiyah (n = 1,200) regions 
using the stratified multi-stage sampling method. The 
intention behind selecting these two regions was to 
magnitude of asthma worldwide and sought to discern 
the factors contributing to its prevalence.5
The first phase of the ISAAC Program involved 
700,000 children and adolescents from 156 centres in 
56 countries, demonstrating the widespread concern 
associated with asthma and allergic disorders. The 
data collection methodology involved the use of simple 
questionnaires, thus allowing an easy comparison of 
data from different countries.6 The results of the study 
showed that the symptoms of asthma vary largely 
even in populations that share genetic similarities, 
thereby suggesting that environmental factors play an 
important role in the disease pathophysiology.7–10
Several aspects of the environment were 
incorporated into the ecological data analysis 
from phase one of ISAAC. Of these, economic 
development, dietary factors, climate, infections and 
pollen were implicated as factors contributing to this 
phenotypical variation.11–16 The second phase involved 
the use of detailed questionnaires with measurements 
of physiological variables and indoor exposure.17 The 
third phase took the form of a cross-sectional survey 
across several countries, primarily targeting two groups 
of children aged 6–7 years and 13–14 years, respectively. 
This was conducted five years after phase one of the 
ISAAC Program, which served as a baseline.17
There was a six-year gap between the 
implementation of these three phases of the ISAAC 
Program in Oman. During the first two phases, groups 
of 6–7-year-olds and 13–14-year-olds were involved. 
The proportion allocations method was used to get 
national samples, which were arbitrarily chosen from 
10 regional areas of Oman.
In phase one of ISAAC, which took place in April 
1995, Arabic questionnaires were distributed (N = 
7,625) of which 4,079 were given to 6–7-year-olds and 
3,546 were given to 13–14-year-olds. In phase three, 
which was conducted in April 2001, questionnaires 
were again distributed (N = 8,080), of which 4,235 
were given to 6–7-year-olds and 3,853 were given 
to the 13–14-year-olds. An ISAAC Arabic asthma 
video questionnaire was also completed by the 
13–14-year-olds.7
In 1995, Oman’s prevalence rate of reported 
asthma diagnoses, as seen in phase one of the ISAAC 
results, was higher in older children (20.7%) than in 
younger children (10.5%).18 Among older children, 
283 were current wheezers, of which 30% were 
suffering from sleep-disturbing wheezing at least once 
a week and 37.5% had had speech-limiting wheezing 
during the previous year. In younger children, 277 
were current wheezers, of which 40.8% had sleep-
disturbing wheezing at least once a week while 45.1% 
had had speech-limiting wheezing during the previous 
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draw a comparison between the potential offending 
environmental factors that were responsible for the 
different prevalence rates as seen in phase one. The 
statistics from the Muscat region can be considered 
representative of the national average as, being the 
capital city, it houses individuals from all over the 
country. The south Ash Sharqiyah region, however, had 
the highest prevalence rate of all asthma symptoms. 
The results of this survey showed that the south Ash 
Sharqiyah region continued to report the highest 
prevalence of asthma symptoms in Oman. It also 
identified exposure to Arabian incense as a common 
trigger for asthma symptoms in Omani children.22
The Cost of Asthma in Oman Study addressed 
the prevalence and cost of asthma management in 
Oman.23 A revised Delphi method was used to collect 
the agreement of data estimations from an asthma 
management expert panel which consisted of 10 expert 
physicians in asthma management from Oman.23–26 One 
important advantage of this method over a face-to-face 
group panel method was to obtain information from 
each involved member without the influence of others 
on the panel. This study found that the prevalence of 
asthma in Oman was estimated to be 7.3% of adults 
(n = 96,470) and 12.7% of children (n = 58,344). Of this 
group, 95% used governmental healthcare services.23
Control of Asthma in Oman
Despite an international agreement on the goals 
of asthma management, available epidemiological 
statistics from Europe, the USA and other countries 
indicate that the treatment of patients with asthma is 
very poor.27
The Asthma Insights and Reality in the Gulf and 
the Near East (AIRGNE) study was conducted in five 
countries including Oman, the United Arab Emirates 
(UAE), Kuwait, Jordan and Lebanon. The study aimed 
to examine and evaluate asthma characteristics and 
the quality of asthma management and control in 
these countries.28 In addition, the study was intended 
to define asthma management and evaluate how 
closely the Global Initiative for Asthma (GINA) 
guidelines were being followed.29 The AIRGNE study 
also assessed other aspects of asthma, such as patient 
knowledge and perceptions of asthma symptoms.28
In Oman, the AIRGNE study was performed in the 
most populated cities including Muscat (and the areas) 
Seeb and Mutrah, Sohar and Nizwa. The sampling 
was designed by gender and age within each city.28 
Asthmatic patients reported that they had experienced 
significant daytime asthma symptoms (68%) and 
nocturnal symptoms (51%) in the previous four weeks. 
The participants also reported frequent use of health 
facilities in the previous year with frequent emergency 
room (ER) visits (52%) and hospitalisations (23%) 
leading to work and school absences. Lung function 
testing was generally underemployed, with 66% never 
having undergone a lung function test. Peak expiratory 
flow was used only by a small proportion of the patients 
and only 17% owned their own peak flow meters.28
The overall AIRGNE results showed that the 
level of asthma control in the studied countries 
lagged far behind the GINA guidelines for asthma 
management.28,29 However, there were differences in 
the level of control in each country. In Oman, there were 
wide-ranging discrepancies in asthma perceptions. 
While 57% of asthmatics perceived their asthma 
symptoms as “well or completely controlled”, 54% had 
“poorly or not well-controlled” asthma. Advice issued 
for asthma control by GINA was mostly disregarded, 
especially in children, evidenced by the fact that 44% 
cited nocturnal awakenings due to asthma symptoms 
in the previous four weeks and 47% recalled exercise-
induced asthma symptoms in the previous year. These 
incidents led to a large number of patients reporting 
asthma-related school/work absences in the preceding 
year (32.6% of children and 34.8% of adults).28
One finding of concern was that only 5% of 
Omani asthmatics were found to be using preventive 
medications in the form of inhaled corticosteroids 
(ICS). This figure was one of the lowest in the studied 
countries, evidenced by an improper ratio of ICS 
to short-acting beta-agonists (ICS/SABA) of 0.054 
among Omani asthmatic patients.30
Although the results of the AIRGNE study were 
eye-opening, they were comparable to those of a 
study conducted in Oman in 2009.31 In this study, the 
authors evaluated the level of asthma control among 
patients visiting the Chest Clinic in the Royal Hospital 
in Muscat, Oman, using the Asthma Control Test™ 
(QualityMetric Inc., Lincoln, Rhode Island, USA). 
The results of the study revealed that 61% of asthma 
patients scored between 20 and 25, classifying their 
asthma as well controlled. However, 17.7% scored 
between 15 and 19, indicating that their asthma was 
not well controlled. The remainder of patients (21.3%) 
scored between 5 and 14, signifying that their asthma 
was poorly controlled. Half of the patients stated that 
their asthma had a large impact on their work, school 
or home lives.31 A large number of patients (66%) 
reported nighttime symptoms and 70% had used 
rescue medications such as albuterol in the previous 
four weeks. The results showed that patients also had 
an inaccurate perception of their asthma severity; the 
majority of patients (65%) stated that their asthma 
was well controlled but in reality their symptoms 
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puts Oman at the intermediate prevalence level on 
the ISAAC’s international scale for the same age 
group.8 However, among 13–14-year-olds, Oman had 
the highest prevalence of asthma (20.7%) of the seven 
Eastern Mediterranean countries in the ISAAC study. 
In comparison, the following countries had a lower 
prevalence: Iran (2.7%), Kuwait (17.5%), Lebanon (11.7%), 
Malta (11.1%(, Morocco (11.7%( and Pakistan (7.3%).32
In 13–14-year-olds, the prevalence of asthma 
diagnoses and the self-reporting of asthma symptoms 
was higher compared to the younger age group.8 The 
most likely reason for this is a cumulative effect—
asthma which starts early in childhood persists into 
adolescence and, in addition, new cases are diagnosed 
during adolescence.18
A Regional View of Oman’s 
Asthma Control Levels 
The AIRGNE study was the first and most 
comprehensive survey of the current state of asthma 
management in the region. The results of this study 
revealed that the current level of asthma control in 
the region was not up to standard and that Oman’s 
levels were far below the goals outlined by the GINA 
guidelines for long-term asthma management.30 There 
are several aspects of asthma management and control 
in Oman that are as poor or poorer than other parts of 
the world.27 The AIRGNE study showed that asthma 
morbidity in Oman was elevated, with an unacceptably 
high dependence on the use of rescue medications.30 
Several causes have been attributed to this, including 
the poor detection of uncontrolled asthma by doctors; 
inaccurate perceptions by patients of the severity of 
their asthma symptoms; underutilisation of preventive 
asthma medications, namely ICS; poor asthma 
education provided to patients and their families, 
and the very small percentage of asthmatic patients 
undergoing a lung function test for a diagnosis or the 
monitoring of their asthma control levels.30
Asthma is poorly managed in Oman as compared 
to other regions analysed in the different Asthma 
Insights and Reality studies.28,30 Based on the results 
of the AIRGNE survey, 54% of asthmatic patients 
in Oman have uncontrolled or not well controlled 
asthmas according to the definition outlined in the 
GINA guidelines.29,30 The Asthma Insight and Reality 
in Europe (AIRE) and AIRGNE studies both showed 
that approximately 50% of adult patients had daytime 
symptoms. Generally, the average rate of inadequate 
asthma control in the AIRGNE countries (68%) was 
found to be unacceptably high and this rate was 
even higher in Oman (71%).28,30 These findings were 
limited their daily activities and caused frequent 
nocturnal awakenings.31
Moreover, a recent study on the cost of asthma in 
Oman showed that inpatient and ER visits accounted 
for the majority of overall asthma costs (55% and 
25%, respectively), thereby indicating poor control of 
asthma in Oman.23
Cost of Asthma Care in Oman
There are currently no accurate governmental data 
or studies that directly address the issue of the cost of 
asthma care in Oman. However in 2013, Al-Busaidi 
et al. reported the general cost of asthma in Oman 
following a study that was conducted using a modified 
version of the Delphi method.23 The results of the 
study were as follows: hospital stays and ER visits 
contributed to the majority of asthma-related costs in 
Oman (55% and 25%, respectively), whereas outpatient 
visits and asthma medications accounted for 20%. 
In fact, it was found that medication accounted for 
less than 0.2% of the total direct cost of asthma. The 
annual amount spent on asthma management in 
Oman, excluding medication, was found to be Omani 
riyals 34,273,696 for adults and OMR 27,014,735 for 
children.23 It can be assumed that when inpatient and 
ER visits account for a large portion of the total cost of 
asthma management, there is a strong correlation with 
poor asthma control, which in turn leads to a potential 
burden on Oman’s Ministry of Health (MOH).  
Factors Leading to the Varying 
Asthma Prevalence in Oman
The ISAAC studies found that asthma symptoms were 
common in Oman and significant differences were 
seen in the prevalence of asthma and its symptoms 
in different regions, with the Ash Sharqiyah region 
reporting the highest prevalence.18,20,21 The reason 
for these findings remains unknown. However, many 
aspects of the environment were evaluated in the 
environmental and biological assessment in phase one. 
Certain factors might influence the variation seen in 
the prevalence of the disease and its symptoms. These 
factors include economic development, dietary factors, 
climate, infections and pollen levels.11–16 It would be 
beneficial to conduct a study in the Ash Sharqiyah 
region to elucidate the risk factors contributing to these 
regional variations. The investigation of these factors 
would also help in developing a national plan of health 
and environmental strategies to control asthma.18 
The national estimation of the prevalence of 
asthma in 6–7-year-olds is 10.5%. This, therefore, 
The Burden of Asthma in Oman
e188 | SQU Medical Journal, May 2015, Volume 15, Issue 2
similar to those of Al Rawas et al., which showed 
that nearly 60% of all current wheezers among Omani 
schoolchildren noted the presence of at least one asthma 
symptom, indicating severe or uncontrolled asthma.21
The AIRGNE survey revealed that nocturnal 
disturbances were also found to be common in Oman 
(44%).30 This finding parallels that of Al-Riyami et al., 
where the frequency of sleep disturbance in Oman was 
nearly four times that in Iran (3.5% versus 0.9%), twice 
that of Malta (3.5% versus 1.5%) and greater than that 
of Australia (3.5% versus 2.8%).20
Based on the results of AIRGNE, the frequency of 
hospitalisations and ER visits in Oman reported in the 
year before the study was conducted was unacceptably 
high (30% and 58%, respectively), while the existing 
use of preventive medications for asthma, namely ICS, 
was unacceptably low.28,30 The use of ICS in asthma 
patients in Oman was only 5%, which was significantly 
and statistically lower than the average reported in the 
other countries included in the AIRGNE study (14.6%; 
P <0.05). The daily use of rescue medications in Oman 
was extraordinarily high compared to that of other 
AIRGNE countries (92% versus 55.5%, respectively).30
A large number of asthmatic patients in Oman 
overrated their level of asthma control and underrated 
the severity of their disease, as indicated by the 
discrepancy in their subjective perceptions compared 
to objective asthma severity.28 Of the patients with 
asthma, 57% perceived their symptoms as well or 
completely controlled. However, 54% had poorly or 
not well controlled asthma as assessed by the Asthma 
Control Test™ (QualityMetric Inc.) (P <0.05). The 
lung function test is considered an important test 
for asthma diagnosis and level monitoring. Omani 
asthmatics’ performances were very low as only 35% 
of patients stated that they had done a lung function 
test and only 25% had their own peak flow meter.30
Generally, in comparison to other AIRGNE 
countries, Oman had on average the worst asthma 
management as reflected by the very high use of rescue 
medications, the very low number of prescriptions for 
ICS and an unacceptably high frequency of asthma-
related visits to the ER.30
A Global View of Oman’s Total 
Asthma Costs
Al-Busaidi et al. found that the cost of asthma 
management resulted in a significant economic load 
on the healthcare system in Oman.23 Their study 
found the total cost of asthma to be OMR 61,500,293 
per year. Hospital stays and ER visits were the factors 
that mainly drove this expenditure, equating to almost 
80% of direct costs. In contrast, the cost of asthma 
medications was negligible, representing less than 1% 
of the total direct cost of asthma.23
The AIRGNE study determined that 21% of Omani 
asthmatic adults and children had visited the ER 
in the year before the study.30 In comparison, in the 
AIRE study, only 10% of asthmatic patients reported 
visiting the ER in the year before the study.32 The 
AIRGNE study also reported that, in the year prior 
to the study, 30% required overnight hospital stays, in 
comparison to 7% in the AIRE study.30,32 Inpatient stays 
and ER visits are both linked directly to poorer levels 
of asthma control, which leads to a larger cost liability 
on the MOH.23
The annual direct cost of asthma in Europe was 
found to be €7.9 billion distributed between outpatient 
treatment (48%), drug costs (46%) and inpatient care 
(6%).33 Similarly, in the USA, drug prescriptions and 
outpatient visits accounted for the majority of costs, 
comprising nearly 38% of the total cost for asthma in 
children and 49% of the cost in adults.34 The larger 
share of expenses for inpatient care and ER visits for 
asthmatics in Oman appears to reveal a lower level 
of asthma control in contrast to that of asthmatics in 
Europe and the USA.
Recommendations for 
Reducing the Burden of 
Asthma in Oman
Asthma morbidity is largely preventable. It appears 
that this fact is not widely known in Oman, suggesting 
the need to improve levels of understanding and 
communication between asthmatic patients and their 
doctors. Among physicians, there should be an emphasis 
on following the GINA guidelines to achieve and monitor 
asthma control among all patients.29 The authors suggest 
that the most effective way to reach this objective is to 
promote thorough education for all asthmatic patients 
and their families, including information on the regular 
use of preventative steroid inhalers.
Conclusion
The WHO estimates that more than 300 million 
people have asthma worldwide, although there are 
noteworthy discrepancies in its prevalence between 
countries. In Oman, the asthma prevalence is relatively 
high compared to other countries in the region. In 
addition, Oman features regional discrepancies in 
asthma prevalence, with Ash Sharqiyah playing host 
to the highest rate of asthma in the country. The 
reason for this discrepancy is not clear and there is a 
need for further research in order to help with future 
Nasser Al-Busaidi, Zulfikar Habibulla, Malvika Bhatnagar, Nabil Al-Lawati and Yaqoub Al-Mahrouqi
Review | e189
13. Ellwood P, Asher MI, Björkstén B, Burr M, Pearce N, 
Robertson CF; International Study for Asthma and Allergy in 
Childhood Phase One Study Group. Diet and asthma, allergic 
rhinoconjunctivitis and atopic eczema symptom prevalence: 
An ecological analysis of the International Study of Asthma 
and Allergies in Childhood (ISAAC) data. Eur Respir J 2001; 
17:436–43.
14. Weiland S, Husing A, Strachan D, Rzehak P, Pearce N. Climate 
and the prevalence of symptoms of asthma, allergic rhinitis, and 
atopic eczema in children. Occup Environ Med 2004; 61:609–
15. doi: 10.1136/oem.2002.006809.
15. von Mutius E, Pearce N, Beasley R, Cheng S, von Ehrenstein 
O, Bjorksten B, et al. International patterns of tuberculosis and 
the prevalence of symptoms of asthma, rhinitis and eczema. 
Thorax 2000; 55:449–53. doi: 10.1136/thorax.55.6.449.
16. Burr ML, Emberlin JC, Treu R, Cheng S, Pearce NE; 
International Study for Asthma and Allergy in Childhood 
Phase One Study Group. Pollen counts in relation to the 
prevalence of allergic rhinoconjunctivitis, asthma and atopic 
eczema in the International Study of Asthma and Allergies in 
Childhood (ISAAC). Clin Exp Allergy 2003; 33:1675–80. doi: 
10.1111/j.1365-2222.2003.01816.x.
17. Ellwood P, Asher MI, Beasley R, Clayton TO, Stewart AW; 
International Study for Asthma and Allergy in Childhood 
Steering Committee. The International Study of Asthma and 
Allergies in Childhood (ISAAC): Phase three rationale and 
methods. Int J Tuberc Lung Dis 2005; 9:10–6.
18. Al-Riyami BM, Al-Rawas OA, Al-Riyami AA, Jasim LG, 
Mohammed AJ. A relatively high prevalence and severity of 
asthma, allergic rhinitis and atopic eczema in schoolchildren 
in the Sultanate of Oman. Respirology 2003; 8:69–76. doi: 
10.1046/j.1440-1843.2003.00426.x.
19. The International Study of Asthma and Allergies in Childhood: 
The ISAAC story. Sultanate of Oman, Eastern Mediterranean. 
From:isaac.auckland.ac.nz/story/centres/countries.php?cen =66 
Accessed: Oct 2014.
20. Al-Riyami BM, Al-Rawas OA, Al-Riyami AA, Jasim LG, 
Mohammed AJ. Prevalence of asthma symptoms in Omani 
schoolchildren. J Sci Res Med Sci 2001; 3:21–7.
21. Al-Rawas OA, Al-Riyami BM, Al-Kindy H, Al-Maniri AA, 
Al-Riyami AA. Regional variation in the prevalence of asthma 
symptoms among Omani school children. Sultan Qaboos Univ 
Med J 2008; 8:157–64.
22. Al-Rawas OA, Al-Maniri AA, Al-Riyami BM. Home exposure 
to Arabian incense (bakhour) and asthma symptoms in 
children: A community survey in in Oman. BMC Pulmonary 
Medicine 2009; 9:23. doi: 10.1186/1471-2466-9-23.
23. Al-Busaidi NH, Habibullah Z, Soriano JB. The asthma cost in 
Oman. Sultan Qaboos Univ Med J 2013; 13:218–23. 
24. Rosengart MR, Nathens AB, Schiff MA. The identification 
of criteria to evaluate prehospital trauma care using the 
Delphi technique. J Trauma 2007; 62:708–13. doi: 10.1097/01.
ta.0000197150.07714.c2
25. Bramwell L, Hykawy E. The Delphi Technique: A possible tool 
for predicting future events in nursing education. Nurs Pap 
1974; 6:23–32.
26. Kumaran KM, Lemieux M, Satchell G. Problem solving with 
the Delphi technique. Dimens Health Serv 1976; 53:34–5.
27. Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB, 
et al. Worldwide severity and control of asthma in children and 
adults: The global asthma insights and reality surveys. J Allergy 
Clin Immunol 2004; 114:40–7. doi: 10.1016/j.jaci.2004.04.042.
28. Khadadah M, Mahboub B, Al-Busaidi NH, Sliman N, Soriano 
JB, Bahous J. Asthma insights and reality in the Gulf and the 
near East. Int J Tuberc Lung Dis 2009; 13:1015–22.
health strategic plans. The high number of asthma-
related ER visits and admissions to hospital reflect 
the poor control of the condition in Oman. Therefore, 
closely following the GINA guidelines and educating 
asthmatic patients and their families should be 
prioritised in order to improve the management and 
related costs of this disease within Oman.
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